Jacob Soumerai, Md

This study tested a drug called belantamab mafodotin in 10 people with rare lymphomas that had come back or stopped responding to treatment. The drug works like a guided missile, attaching to lymphoma cells and releasing a toxin to kill them. The study was stopped early, but rese…